Low 25-hydroxyvitamin D is associated with increased mortality in female nursing home residents.

CONTEXT Vitamin D deficiency contributes to skeletal diseases and is highly prevalent among institutionalized elderly patients. Whether low 25-hydroxyvitamin D (25[OH]D) concentrations are an independent risk factor for mortality in these patients is, however, unclear. OBJECTIVE We aimed to evaluate whether 25(OH)D concentrations are associated with mortality. DESIGN, SETTING, AND PARTICIPANTS This is a prospective cohort study among elderly female patients (age >70 yr) recruited from 95 nursing homes in Austria. MAIN OUTCOME MEASURES We calculated Cox proportional hazard ratios (HR) for all-cause mortality according to 25(OH)D quartiles. RESULTS We examined 961 study participants (age 83.7 ± 6.1 yr). Median 25(OH)D concentration was 17.5 (interquartile range 13.7-25.5) nmol/liter, and 93% of our cohort had 25(OH)D levels below 50 nmol/liter. During a mean follow-up time of 27 ± 8 months, 284 patients died. Compared with the fourth quartile (25[OH]D >25.5 nmol/liter), the age-adjusted HR (with 95% confidence interval) was 1.49 (1.07-2.10) in the first 25(OH)D quartile (25[OH]D <14.0 nmol/liter), and this association remained significant after multivariate adjustments (HR = 1.56; 95% confidence interval = 1.01-2.40). CONCLUSIONS This Austrian study suggests that the majority of institutionalized female patients are vitamin D deficient during winter and that there was an inverse association of 25(OH)D and mortality. These data underscore the urgent need for effective strategies for the prevention and treatment of vitamin D deficiency, in particular in the setting of nursing homes.

[1]  J. Wetterslev,et al.  Vitamin D supplementation for prevention of mortality in adults. , 2014, The Cochrane database of systematic reviews.

[2]  S. Pilz,et al.  Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. , 2012, The American journal of clinical nutrition.

[3]  W. März,et al.  Vitamin D, cardiovascular disease and mortality , 2011, Clinical endocrinology.

[4]  S. Pilz,et al.  Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[6]  JoAnn E. Manson,et al.  The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.

[7]  K. Bennell,et al.  Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis , 2010, Osteoporosis International.

[8]  S. Cummings,et al.  Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. , 2010, The Journal of clinical endocrinology and metabolism.

[9]  Thomas J. Wang,et al.  Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. , 2010, Autoimmunity reviews.

[10]  S. Boonen,et al.  IOF position statement: vitamin D recommendations for older adults , 2010, Osteoporosis International.

[11]  T. Pieber,et al.  Epidemiology of vitamin D insufficiency and cancer mortality. , 2009, Anticancer research.

[12]  W. Grant,et al.  25-hydroxyvitamin D levels and all-cause mortality. , 2009, Archives of internal medicine.

[13]  W. Grant.  Differences in vitamin D levels likely explain ethnic differences in incidence of congestive heart failure. , 2009, Archives of internal medicine.

[14]  P. Papapetrou,et al.  Severe vitamin D deficiency in the institutionalized elderly , 2008, Journal of endocrinological investigation.

[15]  C. Mathieu,et al.  Vitamin D and human health: lessons from vitamin D receptor null mice. , 2008, Endocrine reviews.

[16]  J. Smit,et al.  Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents , 2007, Osteoporosis International.

[17]  G. Riedmüller,et al.  Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements. , 2007, The Journal of clinical endocrinology and metabolism.

[18]  A. Tiran,et al.  Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. , 2006, The Journal of clinical endocrinology and metabolism.

[19]  R. Cumming,et al.  Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. , 2004, The Journal of clinical endocrinology and metabolism.

[20]  P. Lips,et al.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.

[21]  M. McKenna,et al.  Differences in vitamin D status between countries in young adults and the elderly. , 1992, The American journal of medicine.

[22]  P. Delmas,et al.  The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. , 1988, The Journal of clinical endocrinology and metabolism.